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Variable LM STEMI
N¼63
Patient Characteristics
Age, years 64 (37-94)
Male (%) 59 (80)
BMI, kg/m2 27 (17-39)
Diabetes (%) 31 (42)
CRI Non-HD (%) 17 (23)
ESRD on HD (%) 6 (8)
Prior/Active smoker (%) 33 (45)
Dyslipidemia (%) 44 (60)
Hypertension (%) 53 (72)
Stroke (%) 9 (12)
Prior MI (%) 10 (14)
Prior PCI (%) 13 (18)
Aspirin (%) 48 (65)
Thienopyridine (%) 18 (24)
Beta Blocker (%) 19 (26)
Statin (%) 29 (39)
Creatinine, mg/dL 1.7  2.3
In hospital mortality (%) 20 (27)
ECG Characteristics
Anterior STE (%) 46 (73)
Lateral STE (%) 32 (51)
Inferior STE (%) 5 (8)
aVR STE (%) 36 (57)
Inferior STD (%) 36 (57)
Lateral STD (%) 15 (24)
Leads/ECG with STE (Mean  SD) 3.8  2.3
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score>5, TIMI risk score>4, DES and two vessel disease.
Conclusions: Based on this large registry data of patients with NSTE-ACS and MVD,
stenting was associated with lower risk of mortality at long term follow up when
compared to surgical revascularization strategy The subgroup analysis highlighted
improved outcomes with PCI in high clinical risk cohorts.
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Background: The GOTHIA CARDIOVASCULAR initiative consist of healthcare
providers of which four have a PCI department in Region Västra Götaland, Sweden.
The data was collected from SCAAR (Swedish Coronary Angiography and Angio-
plasty Registry). GP IIb/IIIa was the standard treatment during PCI in patients with
STEMI until the HORIZONS-AMI study was published 2008. After 2008 a gradual
switch to bivalirudin has occurred. The aim of this observational study was to compare
the outcome associated with treatment with glycoprotein IIb/IIIa receptor inhibitors
(GP IIb/IIIa) and bivalirudin during percutaneous coronary intervention (PCI) in
patients with ST-segment elevation myocardial infarction (STEMI).
Methods: The primary endpoint was mortality after 180 days. Missing data were
imputed using multiple imputation method. Survival was analysed with logistic
regression adjusted for age, gender, smoking status, diabetes, hypertension, hyper-
lipidaemia, prior myocardial infarction, prior PCI, prior coronary by-pass surgery, oral
platelet inhibition prior to PCI, vascular access site, severity of coronary disease,
number of stents used, mean diameter of the stent used, drug-eluting stents, cardio-
genic shock, completeness of revascularisation, and procedural success.
Results: Between 2004-2011, 3067 patients were treated with GP IIb/IIIa and 2688
patients were treated with bivalirudin during primary PCI. The adjusted odds ratio
(OR) for bivalirudin compared with GP IIb/IIIa was 1.26 (95% CI 0.98-1.61 p¼0.07).
Conclusions: In this observational study there was no statistical difference in 180 day
mortality in patients treated with bivalirudin compared with gpIIb/IIIa receptor
inhibitors. However there was a trend in favour of gpIIb/IIIa inhibitors.
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Background: Little is known regarding the various clinical predictors of myocardial
recovery in patients presenting with acute myocardial infarction (AMI) undergoing
percutaneous coronary intervention (PCI). Elevated left ventricular end-diastolic
pressure (LVEDP) is commonly observed during AMI, but few studies have examined
the prognostic value of this index. We hypothesized that lower LVEDP at presentation
would be predictive of improved myocardial recovery at 3 months.
Methods: Clinical and echocardiographic data were collected on 1,211 patients pre-
senting to a tertiary care hospital with AMI who underwent PCI between January 2007
and December 2008. Of the total group, there were 254 patients who had both
a baseline and follow up echocardiogram performed with 156 patients having
a depressed left ventricular ejection fraction (EF) of < 50% on baseline echocardio-
gram. Patients were then grouped by LVEDP < 22 or  22 mmHg based on the
median LVEDP of our study population. Myocardial recovery was deﬁned as  5%
increase in EF on follow-up echocardiogram.
Results: There were 116 patients who were included in this study, of which 53
(45.7%) had LVEDP < 22 and 63 (54.3%) had LVEDP  22 (mean LVEDP 17 vs 28
mmHg respectively, p<0.001). There was no difference in the EF between the two
groups on baseline echo (38% vs 39%, p¼0.326). However at follow up, patients in
the low LVEDP group had a higher EF (45% vs 39%, p¼0.019) and a greater
percentage of those patients showed myocardial recovery (60.4% vs 38.1%, p¼0.017).
In multivariate logistic analysis, LVEDP (OR 0.90, 95% CI:0.84-0.97), prior MI (OR
0.12, 95% CI:0.02-0.82), and TR grade (OR 4.31, 95% CI:1.25-14.90) were inde-
pendent predictors of myocardial recovery.
Conclusions: Among patients presenting with AMI undergoing primary PCI, lower
baseline LVEDP was an independent predictor of myocardial recovery. LVEDP is
a simple and routinely obtained marker that may provide prognostic information in the
setting of AMI.B82 JACC Vol 62/18/Suppl B j October 2TCT-251
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Background: ST-elevation MI (STEMI) from culprit left main (LM) coronary artery
lesions is associated with high mortality and morbidity. The electrocardiographic
(ECG) ﬁndings in this presentation are not well described.
Methods: A retrospective analysis of all of STEMI or STEMI-equivalent (ventricular
ﬁbrillation, ventricular tachycardia or resuscitated cardiac arrest) cases (n¼75) with
culprit LM lesions admitted to 5 academic hospitals in the United States and
Singapore was performed. Patients with prior LM coronary intervention, prior CABG,
or prior known LBBB were excluded. ECG and angiographic analysis were performed
in a blinded fashion.
Results: Among 75 cases, 12 presented as VT, VF, or LBBB. The ﬁndings from the
remaining 63 cases of STEMI are summarized in Table 1. The most common ECG
ﬁndings were ST elevation in the anterior leads (73%, n ¼ 46) with reciprocal ST
depressions in the inferior (57%, n¼36) and lateral (51%, n¼32) leads. There was
infrequent concomitant lateral ST (24%, n¼15) or inferior ST (8%, n¼5) elevations.
ST elevations in aVR were present in only 57% of the ECGs analyzed. The mean
number of contiguous leads with STEs is 3.8  2.3.Conclusions: The traditional pattern of anterolateral ST elevation (STE) with inferior
ST depressions (STD) in acute LM STEMI while common, is not the sole ﬁnding in
this cohort. Furthermore, STE in aVR has only a modest association with LM STEMI.
Further analysis correlating ECG ﬁndings with angiographic characteristics is
underway and will be presented.7–November 1, 2013 j TCT Abstracts/POSTER/STEMI/NSTEMI/ACS
